PMID: 8973996Nov 1, 1996Paper

Absence of an effect of levofloxacin on warfarin pharmacokinetics and anticoagulation in male volunteers

Journal of Clinical Pharmacology
S LiaoR K Nayak

Abstract

Some fluoroquinolone drug-drug interactions involving inhibition of the hepatic metabolism of agents such as theophylline and caffeine have been identified. This study was designed to investigate the potential interaction of the fluoroquinolone levofloxacin in a standard multiple-dose regimen with the oral anticoagulant warfarin. Sixteen healthy male volunteers were given a single oral dose of 30 mg warfarin sodium during a multiple-dose regimen of placebo or levofloxacin 500 mg twice daily, in a placebo-controlled, randomized, double-blind, two-way crossover design. Plasma R(+) and S(-) warfarin concentrations and prothrombin times were measured for 6 days after administration of each warfarin dose. The pharmacokinetic parameters of both enantiomers of warfarin were comparable in the absence and presence of levofloxacin, with no significant differences noted in warfarin peak plasma concentration, time to peak plasma concentration, apparent total body clearance, and terminal disposition half-life. Levofloxacin also had no significant effect on warfarin pharmacodynamics, as assessed by baseline-corrected maximum prothrombin time, time to maximum prothrombin time, and area under the prothrombin time-versus-time curve. The lack of...Continue Reading

References

Apr 1, 1992·Antimicrobial Agents and Chemotherapy·K P FuM E Rosenthale
May 11, 1991·Archives of Internal Medicine·H M JolsonT H Grasela
Jun 1, 1991·The American Journal of Medicine·D LinvilleL Graves
Aug 1, 1990·Journal of Clinical Pharmacology·M L RocciT D Bjornsson
Jul 1, 1989·Antimicrobial Agents and Chemotherapy·H C Neu, N X Chin
Sep 15, 1989·Annals of Internal Medicine·F E MottV Hunt
May 1, 1989·Annals of Internal Medicine·T Linville, D Matanin
Nov 1, 1988·Annals of Internal Medicine·J Leor, S Matetzki
Sep 1, 1988·Antimicrobial Agents and Chemotherapy·T UneY Osada
Jan 1, 1986·Antimicrobial Agents and Chemotherapy·I HayakawaM Furukawa
Jul 1, 1987·Clinical Pharmacology and Therapeutics·S ToonM Rowland
Jan 1, 1987·Current Medical Research and Opinion·M VerhoH Grötsch
Dec 1, 1983·British Journal of Clinical Pharmacology·C BanfieldM Rowland
Mar 1, 1995·Antimicrobial Agents and Chemotherapy·R NauM G Täuber
Sep 1, 1994·The Journal of Antimicrobial Chemotherapy·W W YewA F Cheng
Oct 1, 1994·Antimicrobial Agents and Chemotherapy·S P KlemensM H Cynamon
Nov 1, 1994·Annals of Internal Medicine·P S WellsJ Hirsh
Apr 1, 1994·Antimicrobial Agents and Chemotherapy·M KakuN Suyama
Dec 1, 1993·Clinical Pharmacokinetics·J G GillumR E Polk

❮ Previous
Next ❯

Citations

Aug 14, 1998·Journal of Clinical Pharmacology·D J KazieradD K Jorkasky
Dec 11, 2008·Pharmacy World & Science : PWS·Gabriel Mercadal OrfilaRamón Jodar Masanés
Nov 17, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A KarimH N Steinberg
Jul 21, 2007·Southern Medical Journal·Raja S VadlamudiHassan M Ismail
Aug 15, 2001·Antimicrobial Agents and Chemotherapy·E J RandinitisA J Sedman
Oct 20, 2001·Pharmacotherapy·D N Fish
Mar 16, 2005·Pharmacotherapy·Kenneth L McCallH Glenn Anderson
May 1, 2001·Clinical Pharmacokinetics·A AminimanizaniR Jelliffe
Oct 16, 2001·European Journal of Clinical Pharmacology·G Gheno, L Cinetto
Mar 24, 2006·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·Randolph E Regal, Celina Ong Vue
Jan 23, 1999·Clinical Therapeutics·S M WimerM W Garrison
Apr 9, 2008·The American Journal of Geriatric Pharmacotherapy·Amanda Howard-ThompsonTimothy H Self
Jun 28, 2005·Pharmacotherapy·Gregory EschenauerRandolph E Regal
Mar 12, 2003·Pharmacotherapy·Weeranuj YamreudeewongMark C Greenwood
Dec 28, 2005·The American Journal of Medicine·Lynfa F StroudChaim M Bell
Oct 12, 2004·Emergency Medicine Clinics of North America·Katherine M Prybys
May 12, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·S J MartinC G Garvin
Mar 13, 2002·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·W W Yew
Nov 26, 1999·The Annals of Pharmacotherapy·V J Colucci, M P Rivey
Sep 24, 2002·The Annals of Pharmacotherapy·Cade B Jones, Susan E Fugate

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.